AUGMENTIN Drug Patent Profile
✉ Email this page to a colleague
When do Augmentin patents expire, and when can generic versions of Augmentin launch?
Augmentin is a drug marketed by Us Antibiotics and is included in eight NDAs.
The generic ingredient in AUGMENTIN is amoxicillin; clavulanate potassium. There are forty-six drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Augmentin
A generic version of AUGMENTIN was approved as amoxicillin; clavulanate potassium by SANDOZ on March 14th, 2002.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AUGMENTIN?
- What are the global sales for AUGMENTIN?
- What is Average Wholesale Price for AUGMENTIN?
Summary for AUGMENTIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 8 |
| Drug Prices: | Drug price information for AUGMENTIN |
| Drug Sales Revenues: | Drug sales revenues for AUGMENTIN |
| What excipients (inactive ingredients) are in AUGMENTIN? | AUGMENTIN excipients list |
| DailyMed Link: | AUGMENTIN at DailyMed |
US Patents and Regulatory Information for AUGMENTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Us Antibiotics | AUGMENTIN '125' | amoxicillin; clavulanate potassium | FOR SUSPENSION;ORAL | 050575-001 | Aug 6, 1984 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Us Antibiotics | AUGMENTIN '250' | amoxicillin; clavulanate potassium | TABLET;ORAL | 050564-001 | Aug 6, 1984 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Us Antibiotics | AUGMENTIN '200' | amoxicillin; clavulanate potassium | TABLET, CHEWABLE;ORAL | 050726-001 | May 31, 1996 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
